23,992 Shares in UnitedHealth Group Incorporated (NYSE:UNH) Acquired by GF Fund Management CO. LTD.

GF Fund Management CO. LTD. bought a new position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 23,992 shares of the healthcare conglomerate's stock, valued at approximately $12,137,000.

A number of other institutional investors have also recently modified their holdings of UNH. Pinney & Scofield Inc. purchased a new stake in shares of UnitedHealth Group during the fourth quarter valued at $182,000. Parr Mcknight Wealth Management Group LLC purchased a new stake in shares of UnitedHealth Group during the fourth quarter valued at $11,864,000. Public Employees Retirement System of Ohio boosted its position in shares of UnitedHealth Group by 34.3% during the fourth quarter. Public Employees Retirement System of Ohio now owns 559,683 shares of the healthcare conglomerate's stock valued at $283,121,000 after buying an additional 143,093 shares during the last quarter. Pacific Point Advisors LLC purchased a new stake in shares of UnitedHealth Group during the fourth quarter valued at $2,110,000. Finally, Wick Capital Partners LLC boosted its position in shares of UnitedHealth Group by 15.4% during the fourth quarter. Wick Capital Partners LLC now owns 555 shares of the healthcare conglomerate's stock valued at $280,000 after buying an additional 74 shares during the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other news, CEO Stephen J. Hemsley bought 86,700 shares of UnitedHealth Group stock in a transaction on Friday, May 16th. The stock was acquired at an average cost of $288.57 per share, for a total transaction of $25,019,019.00. Following the completion of the acquisition, the chief executive officer now owns 679,493 shares of the company's stock, valued at $196,081,295.01. This trade represents a 14.63% increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Kristen Gil bought 3,700 shares of UnitedHealth Group stock in a transaction on Thursday, May 15th. The stock was purchased at an average price of $271.17 per share, with a total value of $1,003,329.00. Following the completion of the acquisition, the director now directly owns 3,818 shares of the company's stock, valued at $1,035,327.06. This represents a 3,135.59% increase in their position. The disclosure for this purchase can be found here. Insiders acquired a total of 109,408 shares of company stock valued at $31,607,768 over the last three months. 0.33% of the stock is owned by company insiders.

UnitedHealth Group Trading Down 0.2%

UNH stock traded down $0.58 during mid-day trading on Tuesday, reaching $294.99. 19,619,565 shares of the stock traded hands, compared to its average volume of 6,653,563. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a one year low of $248.88 and a one year high of $630.73. The stock has a market capitalization of $267.60 billion, a PE ratio of 19.03, a PEG ratio of 1.37 and a beta of 0.56. The business has a 50-day moving average price of $448.25 and a two-hundred day moving average price of $501.48.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The firm had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same quarter last year, the firm earned $6.91 EPS. Equities research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

Wall Street Analyst Weigh In

UNH has been the topic of a number of recent research reports. Bank of America downgraded UnitedHealth Group from a "buy" rating to a "neutral" rating and lowered their target price for the company from $560.00 to $350.00 in a report on Wednesday, May 14th. KeyCorp cut their price objective on UnitedHealth Group from $575.00 to $450.00 and set an "overweight" rating for the company in a research note on Wednesday, May 14th. Truist Financial restated a "buy" rating and set a $360.00 target price (down previously from $580.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. TD Cowen cut shares of UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 target price on the stock. in a research note on Monday, May 19th. Finally, TD Securities restated a "hold" rating and set a $308.00 target price (down previously from $520.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating, seventeen have issued a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat, UnitedHealth Group has an average rating of "Moderate Buy" and a consensus target price of $441.87.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.